Screening for asymptomatic meibomian gland dysfunction in candidates for refractive surgery is recommended due to a high prevalence of the condition, according to a study published in Journal of Refractive Surgery.Shawn Sapir, MD, of the department of ophthalmology, Barzilai University Medical Center, Israel, and colleagues wrote that irregularities in the tear film, including those caused by meibomian gland dysfunction (MGD), can change baseline measurements critical to the success of refractive surgery.“Although previous investigations have examined MGD in dry eye cohorts, few have